GBAT+IE for Gifted and Talented Individual

Phase-Based Progress Estimates
Rutgers University, Piscataway, NJGifted and Talented Individual+2 MoreGBAT+IE - Other
18 - 40
All Sexes
What conditions do you have?

Study Summary

This trial will compare the feasibility, acceptability, and preliminary efficacy of three adapted versions of Group Behavioral Activation Therapy (GBAT) delivered via telehealth, compared to a Watchful Waiting (WW) group, in autistic adults with anxiety and depression.

Eligible Conditions
  • Gifted and Talented Individual
  • GBAT+ Engagement Booster
  • Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD Deficiency)

Treatment Effectiveness

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Change from pre-treatment to post-treatment (an average of 12 weeks)

Week 12
Behavior Rating Inventory of Executive Function - Adult Form
Change in Clinical Global Impression Severity (CGIS) Scale: Independent Evaluator
Anxiety Disorders
Change in distress on Patient Health Questionnaire (PHQ-9)
Distress Tolerance Test
Mirror Tracing Persistence Task
Week 12
Anxiety Disorders

Trial Safety

Trial Design

3 Treatment Groups

Phase I
1 of 3
Phase 2a
1 of 3
Phase 2b
1 of 3

Experimental Treatment

30 Total Participants · 3 Treatment Groups

Primary Treatment: GBAT+IE · No Placebo Group · N/A

Phase I
Experimental Group · 1 Intervention: GBAT+I, GBAT+E - Phase I · Intervention Types: Other
Phase 2a
Experimental Group · 1 Intervention: Watchful Waiting and Groups - Phase 2 · Intervention Types: Other
Phase 2b
Experimental Group · 1 Intervention: GBAT+IE · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from pre-treatment to post-treatment (an average of 12 weeks)

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
381 Previous Clinical Trials
59,128 Total Patients Enrolled
New Jersey Governor's Council for Medical Research and Treatment of AutismUNKNOWN
1 Previous Clinical Trials
24 Total Patients Enrolled
Vanessa Bal, PhDPrincipal InvestigatorRutgers, The State University of New Jersey

Eligibility Criteria

Age 18 - 40 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with Autism Spectrum Disorders (ASD).
You are willing to join an online telehealth treatment group that focuses on improving the areas mentioned earlier.

Who else is applying?

What state do they live in?
New York33.3%
How old are they?
18 - 65100.0%
What site did they apply to?
Rutgers University100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Are individuals over the age of 40 being invited to participate in this medical trial?

"This trial is only open to patients aged 18-40. For those under the age of 18, there are 162 other trials available, and 28 for seniors above 65 years old." - Anonymous Online Contributor

Unverified Answer

Are there any current vacancies for participants in this evaluation?

"According to, this investigation is currently accepting applicants and was initially posted on September 23rd 2022 before being recently modified on October 25th 2022." - Anonymous Online Contributor

Unverified Answer

What criteria must individuals meet in order to qualify for this research program?

"This clinical investigation seeks 30 individuals with autism aged 18 to 40. Applicants must bear the following credentials: Be between 18 and 40 years old, Have a verified diagnosis of Autism Spectrum Disorder (ASD), Possess access to an electronic device such as a computer or smartphone in order to complete questionnaires and join virtual meetings, Achieve WRAT Reading Comprehension grade equivalent 6th grade or higher, Reside within New York or New Jersey state limits, Express interest in joining a telehealth treatment group that focuses on areas of difficulty mentioned above., Approximately 60% should be White Non-Hispanic; female applicants ought to account for around 40%," - Anonymous Online Contributor

Unverified Answer

How many participants are currently receiving treatment in this experiment?

"Affirmative. Per the information located on, this study is still enrolling participants and was originally published on September 23rd 2022. The trial requires 30 patients to be recruited from one site with the most recent update occurring October 25th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.